S.A. Mason’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-313
| Closed | -$1.91K | – | 317 |
|
2023
Q4 | $1.91K | Hold |
313
| – | – | ﹤0.01% | 310 |
|
2023
Q3 | $1.46K | Hold |
313
| – | – | ﹤0.01% | 310 |
|
2023
Q2 | $3.08K | Hold |
313
| – | – | ﹤0.01% | 310 |
|
2023
Q1 | $3.08K | Hold |
313
| – | – | ﹤0.01% | 310 |
|
2022
Q4 | $5.85K | Hold |
313
| – | – | ﹤0.01% | 301 |
|
2022
Q3 | $6K | Hold |
313
| – | – | ﹤0.01% | 308 |
|
2022
Q2 | $6K | Hold |
313
| – | – | ﹤0.01% | 315 |
|
2022
Q1 | $13K | Hold |
313
| – | – | 0.01% | 306 |
|
2021
Q4 | $19K | Hold |
313
| – | – | 0.01% | 294 |
|
2021
Q3 | $27K | Hold |
313
| – | – | 0.02% | 281 |
|
2021
Q2 | $35K | Hold |
313
| – | – | 0.02% | 267 |
|
2021
Q1 | $35K | Hold |
313
| – | – | 0.03% | 261 |
|
2020
Q4 | $33K | Hold |
313
| – | – | 0.03% | 250 |
|
2020
Q3 | $44K | Hold |
313
| – | – | 0.04% | 217 |
|
2020
Q2 | $101K | Hold |
313
| – | – | 0.11% | 165 |
|
2020
Q1 | $28K | Sell |
313
-333
| -52% | -$29.8K | 0.03% | 245 |
|
2019
Q4 | $26K | Buy |
+646
| New | +$26K | 0.02% | 277 |
|